News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,266 Results
Type
Article (88984)
Company Profile (555)
Press Release (796708)
Multimedia
Podcasts (248)
Webinars (36)
Section
Business (267088)
Career Advice (4166)
Deals (40034)
Drug Delivery (182)
Drug Development (91803)
Employer Resources (208)
FDA (18612)
Job Trends (17500)
News (398939)
Policy (40027)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3066)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (246)
Alzheimer's disease (2050)
Antibody-drug conjugate (ADC) (600)
Approvals (19019)
Artificial intelligence (937)
ASCO (345)
Autoimmune disease (390)
Automation (70)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (264)
Biotechnology (336)
Bladder cancer (219)
Brain cancer (87)
Breast cancer (870)
Cancer (6878)
Cardiovascular disease (583)
Career advice (3603)
Career pathing (54)
CAR-T (399)
CDC (77)
Celiac Disease (3)
Cell therapy (1116)
Cervical cancer (60)
Clinical research (79495)
Collaboration (2497)
Commercialization (1)
Company closure (8)
Compensation (1616)
Complete response letters (117)
COVID-19 (3047)
CRISPR (130)
C-suite (1387)
Cystic fibrosis (170)
Data (9112)
Decentralized trials (3)
Denatured (95)
Depression (207)
Dermatology (108)
Diabetes (736)
Diagnostics (7675)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (475)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (337)
Earnings (102656)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139106)
Executive appointments (1243)
FDA (22934)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2042)
Gene editing (285)
Generative AI (95)
Gene therapy (878)
GLP-1 (1306)
Government (5571)
Grass and pollen (8)
Guidances (427)
Healthcare (21280)
Hematology (198)
HIV (104)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (370)
Immuno-oncology (124)
Indications (229)
Infectious disease (3461)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (341)
Interviews (823)
IPO (18021)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (129)
Layoffs (698)
Leadership (55)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (909)
Lymphoma (495)
Machine learning (70)
Management (68)
Manufacturing (1321)
Marketing (7)
MASH (232)
Medical affairs (1)
Medical device (15329)
Medtech (15533)
Mergers & acquisitions (23393)
Metabolic disorders (1894)
mRNA (283)
Multiple sclerosis (215)
NASH (24)
Neurodegenerative disease (548)
Neuropsychiatric disorders (133)
Neuroscience (3894)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5149)
Now hiring (84)
Obesity (897)
Opinion (384)
Ovarian cancer (255)
Pain (298)
Pancreatic cancer (378)
Parkinson's disease (433)
Partnered (43)
Patents (701)
Patient recruitment (848)
Peanut (72)
People (68262)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24557)
Phase 2 (34530)
Phase 3 (25964)
Pipeline (10600)
Policy (408)
Postmarket research (3561)
Preclinical (11014)
Press Release (72)
Prostate cancer (362)
Psychedelics (80)
Radiopharmaceuticals (384)
Rare diseases (1351)
Real estate (7467)
Recruiting (82)
Regulatory (30779)
Reports (78)
Research institute (2780)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (348)
Series B (253)
Service/supplier (15)
Sickle cell disease (134)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (152)
Tariffs (104)
The Weekly (150)
Vaccines (1341)
Venture capital (143)
Weight loss (608)
Women's health (148)
Worklife (25)
Date
Today (111)
Last 7 days (510)
Last 30 days (2113)
Last 365 days (33400)
2026 (18892)
2025 (33214)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (103)
Alaska (7)
Arizona (417)
Arkansas (16)
Asia (52498)
Australia (9228)
California (14843)
Canada (4169)
China (1683)
Colorado (639)
Connecticut (653)
Delaware (457)
Europe (121061)
Florida (2234)
Georgia (484)
Hawaii (4)
Idaho (70)
Illinois (1301)
India (113)
Indiana (682)
Iowa (25)
Japan (635)
Kansas (145)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1779)
Massachusetts (10852)
Michigan (430)
Minnesota (826)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3930)
New Mexico (35)
New York (3918)
North Carolina (1962)
North Dakota (11)
Northern California (7420)
Ohio (463)
Oklahoma (29)
Oregon (46)
Pennsylvania (2901)
Puerto Rico (33)
Rhode Island (53)
South America (1670)
South Carolina (92)
South Dakota (2)
Southern California (5863)
Tennessee (243)
Texas (2411)
United States (52982)
Utah (445)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1205)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 886,266 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
July 21, 2026
·
4 min read
Press Releases
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
July 21, 2026
·
8 min read
Press Releases
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
July 21, 2026
·
13 min read
Press Releases
Ashlins Pharmaceuticals and Lee’s Pharm Announce Exclusive License and Supply Agreement Valued at Up to $31 Million
July 21, 2026
·
2 min read
Press Releases
Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
July 21, 2026
·
10 min read
Press Releases
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026
July 21, 2026
·
5 min read
Press Releases
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
July 21, 2026
·
6 min read
Press Releases
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
July 21, 2026
·
4 min read
Press Releases
R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis
July 21, 2026
·
5 min read
Opinion
The FDA’s 505(b)(2) pathway is an underestimated engine of value creation
The biopharma industry would do well to re-embrace the 505(b)(2) path, which allows sponsors to draw on previous findings around an existing drug even as they propose modifications to it.
July 21, 2026
·
6 min read
·
Gail McIntyre
1 of 88,627
Next
